Evaluation of the long-term pancreatic effects of constitutive nitric oxide synthase inhibition in dogs

Constitutive and inducible isoforms of nitric oxide synthase (NOS) catalyze the synthesis of nitric oxide (NO) from L-arginine in various tissues and in different pathophysiologic states. Short-term treatment with NOS inhibitors has been associated with pancreatic enzyme elevations and pancreatic acinar cell degeneration; however, long-term pancreatic effects of NOS inhibition are not known. The purpose of this study was to evaluate the subchronic pancreatic effects of L-nitro-arginine (LNA), a compound that preferentially inhibits constitutive NOS isoforms. LNA was administered orally at doses of 10 and 30 mg/kg per day to 6 female dogs/group for 4 weeks. To differentiate whether the pancreatic effects of LNA may be related to its arginine structure, an additional group was given L-arginine (L-Arg) at plasma concentrations similar to the high dose of LNA (30 mg/kg per day). Pancreatic effects were monitored by changes in serum levels of pancreatic enzymes at regular intervals and by microscopic examinations at the end of the study. Both LNA and L-Arg were systematically available throughout the 4-week study period. LNA produced dose-related elevations (1.3–10-fold above concurrent control) in serum levels of pancreatic enzymes (amylase, lipase and trypsin-like immunoreactivity) during the 4-week treatment period with peak elevations occurring during the first week. Histologic assessments of the pancreas conducted at the end of the 4-week dosing period were unremarkable. Additionally, LNA treatment resulted in reduction in heart rate (40%), gastric distension and gastric mucosal erosion and ulceration. No pancreatic, cardiac, or gastric effects were seen with L-Arg, indicating that above effects were likely due to NOS inhibition. Results of this study confirmed previous observations of acute pancreatic alterations following the inhibition of constitutive NOS isoforms. However, these pancreatic alterations appear to be only transient effects as elevations in serum enzymes declined over time and no structural acinar cell damage was seen after continuous treatment with LNA for 4 weeks, suggesting an adaptation to NOS inhibition over time.

[1]  E. Alhan,et al.  The effects of nitric oxide synthase inhibitors on acute necrotising pancreatitis in rats. , 2003, The European journal of surgery = Acta chirurgica.

[2]  T. Onaga,et al.  Effects of nitric oxide donor and nitric oxide synthase inhibitor on ruminal contractions in conscious sheep. , 2001, Research in veterinary science.

[3]  Jaipaul Singh,et al.  Nitric oxide and the pancreas: Morphological base and role in the control of the exocrine pancreatic secretion , 2001, Molecular and Cellular Biochemistry.

[4]  T. Samulski,et al.  Acute pancreatitis associated with administration of a nitric oxide synthase inhibitor in tumor-bearing dogs. , 2000, In vivo.

[5]  T. Sakata,et al.  Effect of nitric oxide synthase inhibitors on the temporal coordination of duodenal contractions and pancreatic exocrine secretion in sheep , 2000, Journal of Comparative Physiology B.

[6]  H. Mashimo,et al.  Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. , 2000, Gastroenterology.

[7]  S. Sumi,et al.  Frontiers of pancreas regeneration. , 2000, Journal of hepato-biliary-pancreatic surgery.

[8]  S. Konturek,et al.  The effects of ammonia on pancreatic enzyme secretion in vivo and in vitro. , 2000, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[9]  A. Andrzejewska,et al.  Nitric oxide protects the ultrastructure of pancreatic acinar cells in the course of caerulein‐induced acute pancreatitis , 1999, International journal of experimental pathology.

[10]  N. Hayashi,et al.  An endothelial nitric oxide synthase inhibitor aggravates CDL-induced acute pancreatitis in rats. , 1999, Pancreas.

[11]  H. Mashimo,et al.  Lessons from genetically engineered animal models. IV. Nitric oxide synthase gene knockout mice. , 1999, The American journal of physiology.

[12]  N. Sata,et al.  The role of calcium in pancreatitis. , 1999, Hepato-gastroenterology.

[13]  M. Menger,et al.  Attenuation of microvascular reperfusion injury in rat pancreas transplantation by L-arginine. , 1999, Transplantation.

[14]  D. Rattner,et al.  On the protective mechanisms of nitric oxide in acute pancreatitis , 1998, Gut.

[15]  B. Mayer,et al.  Biosynthesis and action of nitric oxide in mammalian cells. , 1997, Trends in biochemical sciences.

[16]  B. Gaston,et al.  Expired nitric oxide as a marker for childhood asthma. , 1997, The Journal of pediatrics.

[17]  J. Olesen,et al.  Nitric oxide synthase inhibition in migraine , 1997, The Lancet.

[18]  J. Konturek,et al.  Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans. , 1997, Gut.

[19]  J. Weidner,et al.  Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients , 1996, The Journal of experimental medicine.

[20]  J. Stachura,et al.  Adaptation of pancreas to repeated caerulein-induced pancreatitis in rats. , 1996, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[21]  S. Konturek,et al.  Influence of capsaicin-sensitive afferent neurons and nitric oxide (NO) on cerulein-induced pancreatitis in rats , 1996, International journal of pancreatology : official journal of the International Association of Pancreatology.

[22]  J. Stamler,et al.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. , 1995, Gut.

[23]  D. Bohr,et al.  The role of nitric oxide in the central control of blood pressure. , 1995, Biochemical and biophysical research communications.

[24]  P. Hellström,et al.  Greatly increased luminal nitric oxide in ulcerative colitis , 1994, The Lancet.

[25]  F. Sundler,et al.  Distribution, origin and projections of nitric oxide synthase-containing neurons in gut and pancreas , 1994, Neuroscience.

[26]  R. Coatney,et al.  l‐NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs , 1994, British journal of pharmacology.

[27]  S. Konturek,et al.  Role of endogenous nitric oxide in the control of canine pancreatic secretion and blood flow. , 1993, Gastroenterology.

[28]  S. Moncada,et al.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. , 1992, Annals of the rheumatic diseases.

[29]  D. Rattner,et al.  Hypocalcemia in experimental pancreatitis occurs independently of changes in serum nonesterified fatty acid levels , 1990, International journal of pancreatology : official journal of the International Association of Pancreatology.

[30]  R. Rude,et al.  Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia. , 1990, The Western journal of medicine.

[31]  D. Scarpelli Toxicology of the pancreas. , 1989, Toxicology and applied pharmacology.

[32]  N. Agarwal,et al.  Systemic complications of acute pancreatitis. , 1988, The American journal of gastroenterology.

[33]  S. Durham,et al.  Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. , 1997, The Journal of allergy and clinical immunology.

[34]  J. W. Pate,et al.  Mechanism of calcium and magnesium translocation in acute pancreatitis: a temporal correlation between hypocalcemia and membrane-mediated excessive intracellular calcium accumulation in soft tissues. , 1988, Magnesium.